BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 35226477)

  • 21. The atypical protein arginine methyltrasferase of Entamoeba histolytica (EhPRMTA) is involved in cell proliferation, heat shock response and in vitro virulence.
    Medina-Gómez C; Bolaños J; Borbolla-Vázquez J; Munguía-Robledo S; Orozco E; Rodríguez MA
    Exp Parasitol; 2021 Mar; 222():108077. PubMed ID: 33465379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the Drosophila protein arginine methyltransferases DART1 and DART4.
    Boulanger MC; Miranda TB; Clarke S; Di Fruscio M; Suter B; Lasko P; Richard S
    Biochem J; 2004 Apr; 379(Pt 2):283-9. PubMed ID: 14705965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PRMT blockade induces defective DNA replication stress response and synergizes with PARP inhibition.
    Li Y; Dobrolecki LE; Sallas C; Zhang X; Kerr TD; Bisht D; Wang Y; Awasthi S; Kaundal B; Wu S; Peng W; Mendillo ML; Lu Y; Jeter CR; Peng G; Liu J; Westin SN; Sood AK; Lewis MT; Das J; Yi SS; Bedford MT; McGrail DJ; Sahni N
    Cell Rep Med; 2023 Dec; 4(12):101326. PubMed ID: 38118413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of post-translational protein arginine methylation during HeLa cell cycle.
    Kim C; Lim Y; Yoo BC; Won NH; Kim S; Kim G
    Biochim Biophys Acta; 2010 Sep; 1800(9):977-85. PubMed ID: 20541591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic control via allosteric regulation of mammalian protein arginine methyltransferases.
    Jain K; Jin CY; Clarke SG
    Proc Natl Acad Sci U S A; 2017 Sep; 114(38):10101-10106. PubMed ID: 28874563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PRMT 3, a type I protein arginine N-methyltransferase that differs from PRMT1 in its oligomerization, subcellular localization, substrate specificity, and regulation.
    Tang J; Gary JD; Clarke S; Herschman HR
    J Biol Chem; 1998 Jul; 273(27):16935-45. PubMed ID: 9642256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolutionarily conserved protein arginine methyltransferases in non-mammalian animal systems.
    Wang YC; Li C
    FEBS J; 2012 Mar; 279(6):932-45. PubMed ID: 22251447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arginine Methyltransferases as Regulators of RNA-Binding Protein Activities in Pathogenic Kinetoplastids.
    Campagnaro GD; Nay E; Plevin MJ; Cruz AK; Walrad PB
    Front Mol Biosci; 2021; 8():692668. PubMed ID: 34179098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Role of Protein Arginine Methyltransferases in Inflammatory Responses.
    Kim JH; Yoo BC; Yang WS; Kim E; Hong S; Cho JY
    Mediators Inflamm; 2016; 2016():4028353. PubMed ID: 27041824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetic analysis of human protein arginine N-methyltransferase 2: formation of monomethyl- and asymmetric dimethyl-arginine residues on histone H4.
    Lakowski TM; Frankel A
    Biochem J; 2009 Jun; 421(2):253-61. PubMed ID: 19405910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo analysis of the major type I protein arginine methyltransferase from Trypanosoma brucei.
    Pelletier M; Pasternack DA; Read LK
    Mol Biochem Parasitol; 2005 Dec; 144(2):206-17. PubMed ID: 16198009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein arginine N-methyltransferase substrate preferences for different nη-substituted arginyl peptides.
    Thomas D; Koopmans T; Lakowski TM; Kreinin H; Vhuiyan MI; Sedlock SA; Bui JM; Martin NI; Frankel A
    Chembiochem; 2014 Jul; 15(11):1607-13. PubMed ID: 25044481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro methylation assay to study protein arginine methylation.
    Bikkavilli RK; Avasarala S; Van Scoyk M; Karuppusamy Rathinam MK; Tauler J; Borowicz S; Winn RA
    J Vis Exp; 2014 Oct; (92):e51997. PubMed ID: 25350748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein arginine methyltransferases: evolution and assessment of their pharmacological and therapeutic potential.
    Krause CD; Yang ZH; Kim YS; Lee JH; Cook JR; Pestka S
    Pharmacol Ther; 2007 Jan; 113(1):50-87. PubMed ID: 17005254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arginine Methylation: The Coming of Age.
    Blanc RS; Richard S
    Mol Cell; 2017 Jan; 65(1):8-24. PubMed ID: 28061334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of substrate modifications on the arginine dimethylation activities of PRMT1 and PRMT5.
    Fulton MD; Dang T; Brown T; Zheng YG
    Epigenetics; 2022 Jan; 17(1):1-18. PubMed ID: 33380261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein arginine methyltransferases (PRMTs): Orchestrators of cancer pathogenesis, immunotherapy dynamics, and drug resistance.
    Gao Y; Feng C; Ma J; Yan Q
    Biochem Pharmacol; 2024 Mar; 221():116048. PubMed ID: 38346542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding protein arginine methyltransferase 1 (PRMT1) product specificity from molecular dynamics.
    Gathiaka S; Boykin B; Cáceres T; Hevel JM; Acevedo O
    Bioorg Med Chem; 2016 Oct; 24(20):4949-4960. PubMed ID: 27545444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein arginine methyltransferase biology in humans during acute and chronic skeletal muscle plasticity.
    vanLieshout TL; Bonafiglia JT; Gurd BJ; Ljubicic V
    J Appl Physiol (1985); 2019 Sep; 127(3):867-880. PubMed ID: 31369333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Skeletal muscle-specific Prmt1 deletion causes muscle atrophy via deregulation of the PRMT6-FOXO3 axis.
    Choi S; Jeong HJ; Kim H; Choi D; Cho SC; Seong JK; Koo SH; Kang JS
    Autophagy; 2019 Jun; 15(6):1069-1081. PubMed ID: 30653406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.